Article Details

With FDA nod, Ridgeback's Ebanga joins Regeneron's Inmazeb in the Ebola-fighting arsenal

Retrieved on: 2020-12-22 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

With FDA nod, Ridgeback's Ebanga joins Regeneron's Inmazeb in the Ebola-fighting arsenal. View article details on hiswai:

Excerpt

... approval marks the second for an Ebola drug after Regeneron's Inmazeb, a cocktail of three monoclonal antibodies, claimed the first title in October.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up